GlassScriptPhysician profile
Wesley Reid Pace
NPI 1548795636
$4,847.18
in general payments reported to CMS, 2019-2025
20 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $516 · 2022: $1,028 · 2023: $744 · 2024: $1,095 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,303.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,105.03 | 2021-2025 | Idosetr, Ce-Marked Kxla System, Istent Trabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $614.55 | 2021-2025 | Veritas Vision System, Tecnis Iol, Catalys System |
| Abbvie INC. | $604.52 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $532.21 | 2022-2025 | Cequa |
| Dompe US, INC. | $309.33 | 2021-2025 | Oxervate |
| Alcon Vision LLC | $299.83 | 2022-2025 | Clareon, Rocklatan, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $294.76 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $195.92 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Sight Sciences, INC. | $184.38 | 2022-2024 | Omni Surgical System |
| Genentech USA, INC. | $130.18 | 2022 | |
| Allergan, INC. | $123.77 | 2021 | |
| Biotissue Holdings INC. | $91.61 | 2022-2025 | |
| Amgen INC. | $75.96 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $59.58 | 2021-2022 | |
| Oyster Point Pharma, INC. | $57.78 | 2022-2023 | Tyrvaya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $55.24 | 2022 | |
| Harrow Eye, LLC | $54.66 | 2025 | Vevye |
| Thea Pharma INC. | $22.80 | 2023 | Iyuzeh |
| Rxsight INC | $20.74 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Aerie Pharmaceuticals, INC. | $14.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.